E-LIB Suche - Ergebnisse für: Seegobin, Seth

1

Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevim..:

Hobbs, F. D. Richard ; Montgomery, Hugh ; Padilla, Francisco...
Infectious Diseases and Therapy. 13 (2024) 3 - p. 521-533 , 2024

Link: https://doi.org/10.1007/..

2

Immunogenicity and safety of beta variant COVID-19 vaccine ..:

Costa Clemens, Sue Ann ; Jepson, Brett ; Bhorat, Qasim E...
The Lancet Microbe. , 2024

Link: https://doi.org/10.1016/..

3

Serum AZD7442 (tixagevimab–cilgavimab) concentrations and i..:

Clegg, Lindsay E ; Stepanov, Oleg ; Matthews, Sam...
Clinical & Translational Immunology. 13 (2024) 6 - p. , 2024

Link: https://doi.org/10.1002/..

4

Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevi..:

Levin, Myron J. ; Ustianowski, Andrew ; De Wit, Stephane...
Infectious Diseases and Therapy. 13 (2024) 6 - p. 1253-1268 , 2024

Link: https://doi.org/10.1007/..

5

Immunogenicity and safety of AZD2816, a beta (B.1.351) vari..:

Ramasamy, Maheshi N ; Kelly, Elizabeth J ; Seegobin, Seth...
The Lancet Microbe. 4 (2023) 11 - p. e863-e874 , 2023

Link: https://doi.org/10.1016/..

6

529. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Treatme..:

Richard Hobbs, F D ; Montgomery, Hugh ; Padilla, Francisco...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

7

Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) ..:

Hobbs, F. D. Richard ; Montgomery, Hugh ; Padilla, Francisco...
Infectious Diseases and Therapy. 12 (2023) 9 - p. 2269-2287 , 2023

Link: https://doi.org/10.1007/..

8

Safety, Tolerability and Pharmacokinetics of Half-Life Exte..:

Forte-Soto, Pablo ; Albayaty, Muna ; Brooks, Dennis...
The Journal of Infectious Diseases. 227 (2023) 10 - p. 1153-1163 , 2023

Link: https://doi.org/10.1093/..

9

1353. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Post-e..:

Levin, Myron J ; Ustianowski, Andrew ; Thissen, Jesse...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

10

1354. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Preven..:

Levin, Myron J ; Ustianowski, Andrew ; De Wit, Stéphane...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

11

Efficacy and safety of intramuscular administration of tixa..:

Montgomery, Hugh ; Hobbs, F D Richard ; Padilla, Francisco...
The Lancet Respiratory Medicine. 10 (2022) 10 - p. 985-996 , 2022

Link: https://doi.org/10.1016/..

12

1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing..:

Richard Hobbs, F D ; Montgomery, Hugh ; Padilla, Francisco...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

13

AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophyla..:

Levin, Myron J ; Ustianowski, Andrew ; Thomas, Steven...
Clinical Infectious Diseases. 76 (2022) 7 - p. 1247-1256 , 2022

Link: https://doi.org/10.1093/..

14

LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD74..:

Levin, Myron J ; Ustianowski, Andrew ; De Wit, Stéphane...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S810-S810 , 2021

Link: https://doi.org/10.1093/..

15

Genome-wide association study in frontal fibrosing alopecia..:

Tziotzios, Christos ; Petridis, Christos ; Dand, Nick...
Nature Communications. 10 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..